Geron Correlations

GERN Stock  USD 1.24  0.05  3.88%   
The current 90-days correlation between Geron and Stem Inc is 0.1 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Geron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Geron moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Geron Correlation With Market

Very weak diversification

The correlation between Geron and DJI is 0.44 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Geron and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

Moving together with Geron Stock

  0.72FATE Fate TherapeuticsPairCorr
  0.66CGEN CompugenPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
IMMPVSTM
STEMIMMP
STEMVSTM
EXELAGEN
AGENELEV
EXELIMMP
  
High negative correlations   
AGENVSTM
ELEVVSTM
ELEVIMMP
AGENIMMP
EXELVSTM
STEMELEV

Risk-Adjusted Indicators

There is a big difference between Geron Stock performing well and Geron Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Geron's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Geron Corporate Management

Andrew GrethleinExecutive VP of Devel. and Technical OperationsProfile
Faye MDExecutive OfficerProfile
Joseph MDExecutive DevelopmentProfile
Stephen JDChief VPProfile
Aron FeingoldVice CommunicationsProfile